Early studies of the retinoblastoma gene (RB) have uncovered its critical role as a regulator of the G 1 /S cell cycle phase progression. Surprisingly, genetic approaches in mammals and nematodes have also shown RB controls cell lineage specification and aspects of differentiation. The RB gene product accomplishes this by diverse mechanisms such as by interacting with tissue-specific transcription factors, enhancing RNA interference, and modifying chromatin structure. We review recent studies uncovering novel mechanisms by which RB works in several cell lineages and we provide perspectives on how these new findings might relate to RB tumor suppression.
Introduction
The retinoblastoma tumor suppressor gene (RB) was the first tumor suppressor gene to be cloned (Friend et al., 1986; Fung et al., 1987; Lee et al., 1987) . Heritable RB mutations often resulted in retinoblastoma in which the remaining wild-type allele is also lost (Cavenee et al., 1983; Godbout et al., 1983) . Much insight into its tumor suppressive effects has been gleaned from biochemical and cell biological studies in cultured cells and in vivo. Current models hold that RB principally functions as a tumor suppressor by controlling the expression of genes required for the G 1 -to S-phase transition (reviewed in Classon and Harlow, 2002; Frolov and Dyson, 2004) . More recent evidence suggests additional roles of RB in other phases of the cell cycle (Hernando et al., 2004; Jackson et al., 2005) .
In mammals, RB represents the founding member of a family that includes two other related proteins: p107 (Ewen et al., 1991; Zhu et al., 1993) and p130 (Li et al., 1993; Mayol et al., 1993; Chen et al., 1996a) . Although they share certain biochemical properties, the proteins serve distinct functions in cell cycle regulation and the tumor suppressive effects of p107 and p130 are less clear (reviewed in Classon and Harlow, 2002; WikenheiserBrokamp, 2006) . In contrast to mammals, only one RB ortholog was identified in Drosophila melanogaster and Caenorhabditis elegans. Key regulators (e.g., cyclins, cyclin-dependent kinases (Cdks) and Cdk inhibitors) and effectors (e.g., DP and E2F family transcription factors, chromatin-remodeling proteins) of RB function are conserved in all these organisms (reviewed in Dimova and Dyson, 2005) .
Over 10 years ago, several groups took advantage of homologous recombination in mouse embryonic stem (ES) cells to inactivate the RB gene in vivo (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . They confirmed the fact that RB was a bona fide tumor suppressor gene as mice with only one normal RB allele develop tumors of the pituitary, adrenal, thyroid and parathyroid glands with high penetrance (Jacks et al., 1992; Hu et al., 1994; Nikitin et al., 1999) . This approach also revealed a previously unrecognized, essential function for RB in mouse development -RB À/À embryos did not survive past embryonic day (E) B13.5-14.5 (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . Significant pathology in the developing central and peripheral nervous systems and in erythrocytes seemed to be central to the embryonic lethality. The findings indicated that RB protein function, indeed, extended beyond mere tumor suppression and spawned many studies to better understand the essential functions of the gene during development.
Interestingly, despite the fact that RB plays a critical role in G 1 -/S-phase control in all cell types, RB mutations are very common only in a limited number of cancers -RB, osteosarcoma and small cell lung cancer -while other genes in the RB pathway, including Ink4a and D-type Cyclins, are often mutated in other tumors. That some tumors tend to inactivate RB instead of other genes in the pathway suggests that cell-specific functions extending beyond cell cycle control may also contribute to its tumor prevention. Control of cellular differentiation and lineage specification are likely to represent such effects that are separable from cell proliferation regulation. Here, we review new findings addressing mechanisms by which RB can control these processes in different organisms and a variety of cell types.
Mechanisms by which RB promotes normal mammalian development
The ability to ablate RB in certain cell types at a specific developmental stage in the mouse and the generation of chimeric mice have made it possible to study RB function in vivo. We will review the phenotype and mechanistic insights uncovered using these elegant mouse models (Figure 1 ).
Extra-embryonic functions of RB are essential for mouse embryo development Given the severe pathology evident in RB À/À embryos at E13.5-E14.5, neurological and hematological defects have generally been assumed to cause the embryonic lethality. Recent studies challenge this conclusion. The finding that RB regulators p57
Kip2 and p27 Kip1 play a role in placental development (Zhang et al., 1998) raised the possibility that RB has an essential extra-embryonic function. Indeed, significant dysplasia is evident in the labyrinth layer of the placenta in the absence of RB . This is largely manifested as the accumulation of densely packed trophoblasts compromising blood spaces due to increased placental trophoblast proliferation. The pathology is significant because RBdeficient embryos have decreased levels of several essential fatty acids normally transported across the placenta.
Whether placental defects contribute to embryonic lethality in RB À/À embryos was assessed by aggregation of wild-type tetraploid embryos with RB-deficient diploid ones and by targeted inactivation of RB solely in embryonic tissue. These maneuvers rescue the lethality and largely correct the hind brain apoptosis and the excess nucleated erythrocytes in RB À/À embryos de Bruin et al., 2003) . While this provides striking evidence that certain developmental defects in the brain and erythrocytes are mediated by RB in extra-embryonic tissue, other embryonic defects are not rescued. In particular, excess proliferation and apoptosis in the developing ocular lens and defects in skeletal myogenesis remain. Moreover, the rescued RB À/À pups die shortly after birth due to pulmonary insufficiency possibly stemming from skeletal muscle defects.
Insight into the molecular basis for the embryonic functions of RB has come from mouse genetic studies. Several proteins that promote cell proliferation and/or apoptosis -E2F1, E2F3 and Id2 -are known to physically interact with and be regulated by RB. Loss of each gene partially extends the embryonic viability of RB À/À embryos and partially or completely rescues ectopic cell proliferation and apoptosis in the developing nervous system and lens and some of the morphological Figure 1 Regulation of cell lineage specification by RB. RB promotes differentiation in a variety of cell types. RB physically or functionally interacts with a variety of transcription factors or signaling proteins (indicated in ovals) to promote differentiation in certain cells or tissues in the mouse (blue) and in C. elegans (yellow). Molecular mechanisms by which RB promotes certain aspects of the differentiation program is not clear for some tissues (like pulmonary neuroendocrine cells and retina). In many cases, genetic and/or biochemical evidence indicates whether the effects of RB are positive (arrows) or negative (blocked arrows) to promote cellular differentiation or specification. The tissue-specific aspects of RB often appear to be distinct from its regulation of cell proliferation and/or apoptosis. MRFs: myogenic regulator factors like MyoD, Mef2. Other terms are defined in the text. abnormalities in erythrocytes (Tsai et al., 1998; Lasorella et al., 2000; Ziebold et al., 2001) . Skeletal muscle and pulmonary defects still persist in these embryos and new defects in cardiac muscle are unmasked in RB
E2f3
À/À embryos (discussed further below). How loss of RB deregulates these key effectors and whether the genetic manipulations that partially reverse the embryonic lethality operate by correcting the extra-embryonic effects of RB deficiency is not yet established.
RB promotes erythrocyte maturation by non-cell autonomous mechanisms
Earlier analyses showed that chimeric mice composed of wild-type and RB À/À cells had minimal erythrocyte abnormalities (Maandag et al., 1994; Williams et al., 1994) , which again implied that RB had non-cell autonomous functions in erythropoiesis. The wild-type extra-embryonic tissue only partially rescues the hematological manifestations of RB deficiency, indicating that additional mechanisms were operative .
As the morphology of the peripheral blood in RB
Id2
À/À double knockout mice is normal (Lasorella et al., 2000) and RB and Id2 physically interact (Iavarone et al., 1994) , cDNA expression arrays were used to understand how concurrent inactivation of Id2 influenced the effects of RB loss in mouse embryo fibroblasts (MEFs) (Iavarone et al., 2004) . Surprisingly, some of the genes whose expression decreases in RB À/À MEFs and increases in RB
À/À MEFs belong to the macrophage/dendritic cell lineage. Macrophages play an essential role in definitive erythropoiesis (Kawane et al., 2001) . Indeed, significantly fewer mature macrophages reside in fetal livers of RB À/À embryos and their numbers are restored by loss of Id2. Both genes are expressed in mature fetal liver macrophages and the proteins physically interact in co-immunoprecipitation assays. In the absence of RB, the normal physical interactions between macrophages and developing erythrocytes does not occur (Iavarone et al., 2004) . Decreased cell-cell interactions are also found in vitro: RB À/À fetal liver macrophages adhere poorly to wildtype erythrocytes whereas RB
À/À macrophages associate normally with erythrocytes. Finally, RB À/À erythroblasts avidly bind to wild-type macrophages. This interaction during erythrocyte maturation promotes enucleation, a process defective in RB À/À embryos. However, despite the persistence of maturation defects, no erythroleukemia develops when RB À/À fetal liver cells are transplanted into irradiated wild-type mice (Hu et al., 1997) . Taken together, these findings clearly indicate that part of the contribution of RB to erythropoiesis depends on a mechanism that is extrinsic to the erythrocyte.
How could loss of RB alter macrophage maturation in a manner that depends on Id2? Pu.1 is an Ets-related transcription factor that activates the expression of macrophage genes (Anderson et al., 1998; DeKoter et al., 1998) and physically interacts with RB (Rekhtman et al., 2003) . Pu.1 directly binds the Fms intronic response element in the colony-stimulating factor-1 receptor promoter; Id2 expression inhibits this binding and ectopically expressed RB reverses the inhibition (Iavarone et al., 2004) . Changes in the bound proteins parallel their effects on the expression of Pu.1-responsive promoters and endogenous genes. Importantly, the ability of ectopic RB to promote Pu.1-dependent gene expression depends on co-expressed Id2. These findings provide an elegant molecular model by which RB exerts cell intrinsic effects in macrophages to promote erythrocyte maturation. How these effects relate to the ability of RB expression in placental tissue to at least partially rescue hematopoietic defects must be still critically evaluated.
RB facilitates the differentiation of multiple types of cells in the mouse
Numerous studies have shown that RB promotes differentiation in a wide variety of mammalian cells. As a result of its clear role in cell cycle regulation, it seems logical to assume that its functions in cellular differentiation are secondary to cell cycle control. This is not always the case as elegantly shown by the finding that mechanosensory hair cells in developing embryos fail to exit the cell cycle in RB À/À mice, but the differentiation of individual cells appears to be largely intact (Mantela et al., 2005; Sage et al., 2005) . In this section, we present results of recent studies providing additional insight into how RB promotes cellular differentiation.
Skeletal and cardiac myogenesis
Evaluation of RB-deficient embryos did not show defective skeletal myogenesis due to its early embryonic lethality, but analyses of RB À/À myoblasts and MEFs expressing the myogenic transcription factor MyoD showed that RB is required for myogenic transcription factors to highly induce certain muscle-specific genes Skapek et al., 1996) and promote cell cycle exit (Schneider et al., 1994; Novitch et al., 1996) . In this capacity, RB appears to function early in the transition from a proliferating myoblast to a differentiating myocyte (Huh et al., 2004) ; the postmitotic state of differentiated skeletal myocytes is maintained without RB (Camarda et al., 2004; Huh et al., 2004) . Findings in cultured cells were subsequently shown to be true in vivo upon generation and analysis of RB À/À embryos partially rescued by several methods (discussed above) (Zacksenhaus et al., 1996; Tsai et al., 1998; Lasorella et al., 2000; Ziebold et al., 2001; Iavarone et al., 2004) .
Exactly how RB facilitates myogenic differentiation is not clear. It was generally assumed that its capacity to promote cell cycle arrest and prevent apoptosis would be important. Interesting findings from genetic studies, though, suggest an alternative explanation. Mark Ewen and colleagues previously showed activation of the Rassignaling pathway in MEFs lacking RB . Building on this finding, they further showed that haploinsufficiency for K-Ras or loss of N-Ras allows RB À/À null embryos to survive until E15.5 and E17.5, respectively (Takahashi et al., 2003 (Takahashi et al., , 2004 . In each case, Ras deficiency restore myosin heavy chain and muscle creatine kinase expression, and myotube length to wildtype levels. Further, loss of N-Ras restores the ability of ectopically expressed MyoD and Mef2c to trans-activate plasmid reporters driven by the muscle creatine kinase and Mef2-specific promoters in RB À/À , N-Ras À/À fibroblasts (Takahashi et al., 2003) . Surprisingly, although myofibers appear morphologically normal in the embryo, they still contain giant and apoptotic nuclei observed in RB À/À embryos. Hence, RB may negatively regulate K-or N-Ras -or Ras-activated proteins -to foster skeletal myogenesis in a manner that is distinct from how it blocks cell cycling and apoptosis.
Although some parallels with skeletal muscle differentiation exist -like the importance of MEF2 activity (Srivastava and Olson, 2000) -a role for RB in cardiac myogenesis has been less clear. Recent work indicates that MEF2 may contribute to the thinned myocardium seen in mice lacking E2F3 (Cloud et al., 2002) and in RB, E2F3 compound mutants (Ziebold et al., 2001 ) have a thinned myocardium. This possibility is supported by delayed cardiac muscle differentiation observed in cultured RB À/À mouse embryonic stem cells (Papadimou et al., 2005) . At a molecular level, the delay seems to be due to defects in early stages of cardiac myogenesis because key transcription factors Nkx2.5 and Mef2c are decreased without RB. Moreover, their ectopic expression rescues the defective cardiac muscle differentiation. Interestingly, knock down of Lek1, a transcription factor recently found to physically interact with RB protein (Ashe et al., 2004) , elicits a similar differentiation delay in this model (Papadimou et al., 2005) . Although the physical interaction between RB and Lek1 seems to be important in this process, how they cooperate early in cardiac myogenesis and if this relates to cardiac muscle defects evident in RB À/À , E2f3 À/À deficient embryos are not known.
Adipogenesis
Although not obvious in RB À/À embryos, analyses of MEFs derived from them indicated that RB promotes adipocyte differentiation by virtue of its physical and functional interactions with CCAAT/enhancer-binding proteins (Chen et al., 1996b; Puigserver et al., 1998a) . More recent work has uncovered a specific function during the formation of brown adipocytes, which dissipate energy. Brown adipocyte development and physiology are governed in part by the activities of the peroxisome proliferator-activated receptor (PPAR)-g and its co-activator, PGC-1a (Puigserver et al., 1998b; Picard et al., 2002) and the Forkhead transcription factor Foxc2 (Cederberg et al., 2001) . It is also facilitated by expression of the SV40T antigen (Hansen et al., 2004) , which suggests that RB might normally impede brown adipogenesis. Consistent with this idea, the absence of RB enhances brown adipocyte differentiation in MEFs and embryonic stem cells exposed to the PPAR-g ligand rosiglitazone (Hansen et al., 2004) . This correlates with (1) higher expression of the transcription factors Foxc2 and PPARg, and key coactivators PGC-1a and b; (2) induction of metabolic enzymes like ATP synthase b, cytochrome c oxidase II, and the uncoupling protein (UCP)-1; and (3) increased activity of cyclic AMP-dependent protein kinase A (PKA). PKA is likely integral to the effects because the selective PKA inhibitor H-89 blocks brown adipogenesis that occurs without RB. Results from cultured cells correlate with in vivo findings in that immunostaining shows the absence of RB in brown adipocyte precursors in the mouse and RB protein is hyperphosphorylated (inactive) in mice where brown adipocyte transdifferentiation is induced by cold exposure (Hansen et al., 2004) .
Neuroendocrine cells in the lung
Although genetic manipulations can rescue embryonic lethality, loss of RB is still associated with perinatal death due to pulmonary insufficiency (discussed above). To evaluate its role in lung development or physiology, selective inactivation of RB in the respiratory epithelium was achieved by crossing mice in which the RB gene was flanked by loxP sites to transgenic mice in which a bronchiolar-alveolar-specific promoter directed Cre expression (Wikenheiser-Brokamp, 2004) . Absence of RB in these mice causes epithelial hypercellularity and dysplasia throughout the airway, and it specifically increases the number of lung epithelial cells expressing the neuroendocrine cell marker CGRP. The number of Clara cells and the degree of ciliated cell differentiation are not affected. Unexpectedly, focal hypercellular neuroendocrine lesions persist in adult mice but the remainder of the airway epithelium normalizes. Airway normalization in adult mice is due to functional compensation by other RB family members, p107 and p130. This is indicated by the finding that transgenic expression of SV40 T121 antigen, which binds and inactivates these 'pocket' proteins, causes generalized epithelial hyperplasia that persists throughout the airway in adult mice. Exactly, how loss of RB fosters neuroendocrine cell accumulation is not clear, but the finding suggests a new role of RB in suppressing lung neuroendocrine cell specification or differentiation. The finding that RB has a specific role for this cell type is particularly interesting because small cell lung cancer composed of neuroendocrine cells developed in mice with both RB and p53 targeted in the airway (Meuwissen et al., 2003) . Further, these studies provide an explanation for the long-recognized role of RB itself as a tumor suppressor in small cell lung cancer whereas the entire RB family of proteins are likely functionally inactivated by other mechanisms to promote non-smallcell lung cancer (reviewed in Minna et al., 2002) .
Osteoblastic differentiation
Osteosarcoma is another type of cancer in which RB gene mutations are relatively common. Analogous to its dual role in neuroendocrine cell development and suppression of small cell lung cancer (SCLC), RB also promotes osteoblast differentiation. This was first suggested by work from the Kaelin laboratory showing that ectopic expression of RB in an osteosarcomaderived cell line induces a senescence-like state and morphological changes suggesting osteoblastic differentiation (Sellers et al., 1998) . In cultured MEFs, RB is required for osteoblastic differentiation induced by BMP-2, whereas p107 and p130 are dispensable (Thomas et al., 2001) . The osteoblast transcription factor CBFA1 is essential for normal bone formation (reviewed in Ducy et al., 2000) . CBFA1 levels are similar in wild-type and RB À/À fibroblasts. Both RB and CBFA1 directly bind to osteoblast-specific promoters and RB facilitates CBFA1-dependent gene expression. Naturally occurring mutated forms of RB fail to promote osteoblastic differentiation. Hence, pro-differentiation effects of RB during osteogenesis might have a tumor suppressive effect by promoting cell cycle arrest that accompanies terminal differentiation.
Thyrocytes
As noted above, RB þ /À mice frequently developed thyroid tumors (Nikitin et al., 1999) . Consistent with the theme that tumor susceptibility may be coupled to RB-mediated effects in development, Miccadei et al. (2005) recently found a molecular basis by which RB may promote thyrocyte differentiation. Building on the previous observation that the Pax 8 transcription factor is essential for normal thyrogenesis in the mouse (Mansouri et al., 1998) , they found that RB and Pax 8 physically interact. Further, they cooperate to induce the expression of the Pax 8-responsive TPO promoter, which is directly bound by RB (Miccadei et al., 2005) . A more general role for RB to facilitate the activity of Pax transcription factors is further supported by the fact that Pax 2 also interacts with RB (Yuan et al., 2002) . Based on these findings, one would predict that tissue-specific inactivation of RB in the thyroid gland would result in impaired development.
Neurogenesis in the retina
The fact that children with germline RB mutations nearly always develop retinoblastoma indicates the importance of this gene in retina biology. However, the absence of retinoblastoma in RB þ /À mice suggests that functional redundancy in the mouse might prevent tumor formation. Indeed, mouse models have shown that either p107 or p130 can serve this redundant role because retinoblastoma-like tumors develop when either is disrupted with RB in the retina (Robanus- Maandag et al., 1998; MacPherson et al., 2004; Zhang et al., 2004b) .
Whether RB itself plays an essential role in retina development has now been assessed in vivo by three research groups using slightly different approaches. In each case, a 'floxed' RB allele was inactivated by transgenic expression of Cre; the results varied somewhat depending on the promoter used to drive Cre expression.
Chx10-Cre, RB loxP/loxP mice lack rod photoreceptors but cones and other retinal neuronal cells are unaffected (Zhang et al., 2004a) . In Nestin-Cre, RB loxP/loxP and Pax6-Cre, RB loxP/loxP mice, photoreceptors as well as bipolar and ganglion cells are lost (Chen et al., 2004; MacPherson et al., 2004 ). This appears to be a cell-autonomous effect because defective rod development is also observed in individual cells where RB is targeted by retroviralmediated Cre expression (Zhang et al., 2004a) . Loss of photoreceptor differentiation in this model is consistent with a previous study where RB family proteins were functionally inactivated due to transgenic expression of Cyclin D1 under control of the Interphotoreceptor retinoid-binding protein promoter (Skapek et al., 2001) . In all these cases, excess proliferation that occurs in the maturing retina without RB is balanced by apoptosis, which likely results in decreased numbers of photoreceptors (Chen et al., 2004; MacPherson et al., 2004; Zhang et al., 2004a) . Similar to what appears to happen in other cell types, RB may more or less directly promote retinal cell differentiation by functionally interacting with key transcription factors.
Analyses of non-mammalian organisms reveal new mechanisms by which RB might function in development
C. elegans and Arabidopsis have served as valuable model systems to pursue molecular and genetic studies of fundamentally important processes that are conserved in mammals. This may hold true for understanding the RB pathway as well. New evidence from these models shows that RB, indeed, controls cell lineage specification/differentiation and stem cell pools in C. elegans. In this capacity, its ability to control chromatin remodeling and RNA interference (RNAi) machinery may be particularly important.
RB ortholog LIN-35 controls cell lineage specification in C. elegans Only one RB-like protein, LIN-35, is present in the C. elegans genome (Lu and Horvitz, 1998) . Interestingly, lin-35 and three other C. elegans genes related to the mouse 'RB pathway' -lin-53 (the ortholog of mammalian RB-associated protein, RbAp48, Qian et al., 1993) , dpl-1 (ortholog of mammalian DP), and efl-1 (ortholog of mammalian E2F) -antagonize the Ras pathway during vulval development (Lu and Horvitz, 1998; Ceol and Horvitz, 2001 ). In C. elegans, two functionally redundant pathways, SynMuvA and SynMuvB, regulate vulval development. Mutation of a single gene in either pathway or two genes in the same pathway does not alter vulval development. Only SynMuvA/SynMuvB double mutants display a synthetic multivulva (Muv) phenotype, which is the result of extra cells adopting the vulval fate (Ferguson and Horvitz, 1989) . These two redundant pathways antagonize the receptor tyrosine kinase/Ras-signaling pathway during vulval induction. Mosaic analyses demonstrated that LIN-35 activity in the major hypodermal syncytium -not in the vulval precursor cells as previously thought -is required to inhibit vulval fates (Myers and Greenwald, 2005) . Whether LIN-35 antagonizes the effects of the EGF receptor-Ras pathway by regulating secreted signals in hypodermal cells or by perturbing the hypodermal cells and negatively impacting new cells in the syncytium remains to be clarified.
LIN-35 influences lineage specification/differentiation beyond vulval development in C. elegans. A genetic approach to isolate lin-35 synthetic-lethal mutations identified a redundant role for ubc-18, which encodes an E2 ubiquitin-conjugating enzyme related to human UBCH7. Ubc-18 and LIN-35 cooperate to control pharyngeal morphogenesis (Fay et al., 2003) . Twohybrid screen identified the ubiquitin ligase working downstream of ubc-18 to be one of the RBR ubiquitin ligases, ARI-1 (Qiu and Fay, 2006) . While substrates of ubc-18/ARI-1 critical in pharyngeal morphogenesis are unknown, it is likely that ubiquitin modification of some transcription factor works synergistically with LIN-35 to control pharyngeal development.
RB and RNAi in somatic cell specification in C. elegans One potential way LIN-35 might influence cell specification involves its newly uncovered function in RNAi. RNAi was first discovered in C. elegans as a mechanism for post-transcriptional gene silencing induced by exogenous dsRNA (Fire et al., 1998) . It is now known that short RNA regulatory molecules, micro-RNA and short interfering RNAs (siRNA), control many cellular processes by complementary base-pairing with their target sequences in expressed transcripts. Surprisingly, RB pathway mutants show somatic misexpression of germline P granules and enhanced RNAi (Wang et al., 2005) . P granules are electron-dense cytoplasmic organelles composed of RNA-binding proteins and mRNAs that specify germline fates and somatic patterning. Consistent with the enhanced RNAi phenotype of RB pathway C. elegans mutants, the nervous system, which is usually refractory to siRNA, becomes susceptible to RNAi targeting of neuronal genes. It is hypothesized that the chromatin-remodeling complex may activate germ cell genes in the somatic neuronal cells when the RB pathway is disrupted. Although this finding provides potential insights into cell lineage transformation due to RB mutation in mammals (Wang et al., 2005) , siRNA also functions in nuclear division in the intestine of C. elegans , perhaps by influencing chromatin modification (Grishok and Sharp, 2005 and below) . This implies that the interplay between RB and RNAi pathways is likely to be important for cell cycle control and cell-type specification.
Do the interactions of RB with the chromatin-remodeling complex and RNAi machinery influence cell-type specification? RB controls many different aspects of development; the underlying mechanisms may be due to its effects on two major cellular processes: RNAi machinery and chromatin remodeling, both are required for germline maintenance in C. elegans. Maintaining the germ line is critical for all sexually reproducing organisms. Genetic studies show that mobile transposons are inactivated as one mechanism to protect the germline genome: transposition occurs more frequently in somatic cells than germ cells (Collins et al., 1987) . Studies in recent years show that transposon silencing can be mediated by RNAi machinery (Grishok et al., 2000; Sijen and Plasterk, 2003) . As illustrated in Figure 2 , RB may repress germline-specific RNAi to specify somatic cells by mobilizing transposons. This model is consistent with findings in C. elegans where an exogenous gfp transgene can be inactivated by RNAi in somatic cells with mutations in RB pathway genes; in contrast, the transgene is not inactivated by RNAi in wild-type somatic cells (Wang et al., 2005) . Genetic evidence indicates that at least some components of the RNAi machinery are required for enhanced RNAi in the setting of RB pathway mutants. For example, mut-7 is involved in inhibiting transpositions as well as RNAi (Ketting et al., 1999) . In contrast to the lin-35 mutant, the mut-7/lin-35 double mutant does not respond to dsRNA, which is similar to that of the mut-7 single mutant (Wang et al., 2005) . As the majority of RB pathway mutants display enhanced RNAi, RB likely plays negative regulatory roles on at least some RNAi components to allow de-repression of transposons during somatic cells specification. Genome of germ cells is better protected than in somatic cells in C. elegans in that transposons (Tc1, shown as black arrow on the purple line, the DNA molecules) are silenced in germ line but active in somatic cells. Global heterochromatin is strictly regulated in germ cells and linked to methylated histone 3 tail at lysine 9 (H3K9, shown as a light blue-colored ball). Transposon activation is inhibited by germline-specific RNAi components. H3K9 transcriptional repression of heterochromatin region is maintained by hpl-2 (mammalian ortholog: heterochromatin protein 1, HP1), reported to be a key factor during vulval and larval development. Establishment of heterochromatin may require RNAi machinery and mutations of Hpl-2 cause enhanced RNAi. RB controls establishment of heterochromatin and suppression of RNAi components, providing fundamental mechanisms of regulatory roles of RB in developmental processes. See text for additional details.
In addition to transposon silencing, highly ordered chromatin structures are maintained in germ cells (Wylie, 1999) . Histone modifications have been regarded as 'codes' that alter gene expression without changing DNA sequences but by modifying chromatin structure (Jenuwein and Allis, 2001 ). Methylation of histone 3 at lysine 9 (H3K9) promotes germline heterochromatin formation in C. elegans (Kelly et al., 2002) . H3K9-associated heterochromatin is maintained by heterochromatin protein 1 (HP1) binding in many organisms (Maison and Almouzni, 2004) . Functions of hpl-2 (the C. elegans ortholog of HP1) in the germ line and during vulval development (Couteau et al., 2002) have been shown to coordinate with RB (Cardoso et al., 2005) , but detailed mechanisms remain elusive. A possible mechanistic link between RNAi and heterochromatin formation has been raised by findings in yeast where mutants with malfunctioning RNAi machinery fail to establish heterochromatin at centromeres and mating-type loci Volpe et al., 2002) . Although centromeric silencing in C. elegans is relatively difficult to study due to the lack of canonical centromeres, recent investigations demonstrated that RNAi-mediated transgene silencing depends on hpl-2 . Interestingly, mutations in hpl-2 also lead to RNAi enhancement (Couteau et al., 2002) , implying a functional link between RNAi components and heterochromatin establishment. The model shown in Figure 2 speculates on the central role of RB in many different developmental processes through at least two connected pathways, RNAi and chromatin remodeling, leading to gene expression changes by either DNA rearrangements or histone modifications.
In mammalian cells, a chromatin-associated RBinteracting protein, RBP2 has been shown to play an important role in cell differentiation (Benevolenskaya et al., 2005) . RBP2 interacts with a RB mutant that is impaired in E2F binding. RBP2 and RB interaction leads to transactivation of target genes and cell differentiation. Transcriptional activation of RBP2 target genes, two bromodomain-containing proteins, is enhanced by RB in an RBP2-dependent manner. Knockdown of RBP2 promotes differentiation through RB-dependent and -independent pathways. Benevolenskaya et al. (2005) hypothesize that RBP2 inhibits differentiation and binding with RB either displaces RBP2 from specific promoters or collaborates to activate target genes, potentially by maintaining a euchromatic state. The role of RBP2 in differentiation may be ubiquitous; RBP2 influences the differentiation of several cell types. Taken together, this study provides novel mechanistic insights into differentiation function of RB in mammalian cells that is distinct from its activity in cell cycle regulation.
Is there a role of RB in the regulation of stem cell pool size? The contribution of cancer stem cells to solid tumors such as brain tumors (Singh et al., 2004 ) has been demonstrated recently. A role for RB as a regulator of stem cell maintenance was revealed by studies in Arabidopsis. This organism contains a single RB ortholog, the retinoblastoma-related gene, RBR, which controls nuclear proliferation of the female gametocyte (Ebel et al., 2004) . Interestingly, reduced expression of RBR in roots of Arabidopsis increases the number of stem cells without affecting cell cycle duration in mitotically active cells. On the other hand, induced RBR overexpression dispels stem cells prior to arresting other dividing cells (Wildwater et al., 2005) . Epistasis analysis indicates that the patterning gene SCARE-CROW is upstream of RBR in the regulation of stem cell pool size. SCARECROW encodes a transcription factor, the absence of which results in defective quiescent cell specification that is required for maintaining surrounding stem cell status. Based on detailed analyses of the mutant phenotype, Wildwater et al. (2005) speculate that this is likely due to RB's role in promoting differentiation. As discussed above, RB and LEK1 interact to specify embryonic stem cells toward the cardiac lineage (Papadimou et al., 2005) . Conceivably, a role for RB in controlling stem cell pools may underlie aspects of its ability to promote the normal development of other types of cells, like pulmonary neuroendocrine cells or rod photoreceptors.
Concluding remarks and unanswered questions
Despite the expanding interest in the field of cancer biology, many fundamental questions on the biology of RB, the first cloned tumor suppressor gene, remain to be answered. For example, even the fundamental question of the basis for the nearly complete penetrance of retinoblastoma in children with RB mutation is not yet known. Recent studies in Arabidopsis, C. elegans and genetically engineered mice have significantly broadened the conceptual framework for how RB biology should be considered. Beyond its function in cell cycle regulation, these studies have revealed that it plays key roles in cell lineage specification and differentiation and in stem cell biology. Biochemical and genetic approaches provide clues to the molecular basis for these functions, but many questions need to be addressed:
(1) Which proteins in the retina (and other tissues) interact with RB to facilitate its developmental function? (2) What is the relative importance for the cell cycle regulatory and the cell-type-specific developmental functions of RB in its tumor suppression? Are developmental functions for RB also perturbed in tumors harboring mutations in RB regulators, like p16 Ink4a ? (3) Do cell-type-specific associations between RB and chromatin factors exist? Do RB-interacting transcription factors influence these associations? (4) What is the molecular nature of RB repression of the siRNA machinery?
(5) Very few repeat-derived siRNAs have been cloned in mammals. Does heterochromatin establishment in mammal require RNAi? Does RB play a role in this process in mammals?
A better understanding of RB pathways may allow the development of strategies for treating cancer with aberrant RB regulation.
